Free Stock Screener

Help

TURN

180 Degree Capital Corp

Compare

Market cap	$56.02M
Enterprise value	$46.68M

Revenue	$3.650M
EBITDA	$42.276M
Income	-$24.12
Revenue Q/Q	92.06%
Revenue Y/Y	95.44%

P/E	N/A
Forward P/E	N/A
EV/Sales	12.79
EV/EBITDA	1.10
EV/EBIT	N/A
PEG	N/A
Price/Sales	3.02
P/FCF	21.96
Price/Book	0.36
Book/Share	9.29
Cash/Share	N/A
FCF yield	N/A

Employees	35
RPE	$104.274k

Volume	12.920k / N/A
Relative vol.	N/A

EPS	N/A
EPS Q/Q	N/A
Est. EPS Q/Q	N/A

Profit margin	-1,233.86%
Oper. margin	-91.96%
Gross margin	100.00%
EBIT margin	N/A
EBITDA margin	1,158.37%

Ret. on assets	-1.25%
Ret. on equity	-24.44%
ROIC	-18.09%
ROCE	-20.74%

Debt/Equity	1.02
Net debt/EBITDA	N/A
Current ratio	23.14
Quick ratio	22.01

Volatility	1.51%
Beta	0.20

RSI	41.33

Range	$3.32 – $3.40
52 weeks	$3.31 – $4.47
SMA 50	$3 -1.67%
SMA 200	$4 -13.95%

1 year target	$4 +18.69%
Mean Recomm.	N/A

Insider ownership	8.33%
Inst. ownership	25.55%

Shares outst.	10.000M
Shares float	0.000 0.00%
Short % of float	0.11%
Short ratio	1.18

1 year target	$4 +18.69%
Mean Recomm.	N/A

Dividend	$0.00
Dividend yield	0.00%
Payout ratio	N/A
Payment date	N/A
Ex-dividend date	N/A
Earnings date	N/A

IPO year	1983
Country	United States

Compare with other stocks

ACST

Acasti Pharma Inc

Compare

Market cap	$15.38M
Enterprise value	N/A

Revenue	N/A
EBITDA	N/A
Income	-$17.14
Revenue Q/Q	N/A
Revenue Y/Y	N/A

P/E	0.00
Forward P/E	-3.61
EV/Sales	N/A
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	N/A
P/FCF	N/A
Price/Book	0.13
Book/Share	17.88
Cash/Share	N/A
FCF yield	-108.03%

Employees	33
RPE	N/A

Volume	8.492k / N/A
Relative vol.	N/A

EPS	N/A
EPS Q/Q	N/A
Est. EPS Q/Q	N/A

Profit margin	N/A
Oper. margin	N/A
Gross margin	N/A
EBIT margin	N/A
EBITDA margin	N/A

Ret. on assets	-14.03%
Ret. on equity	-16.17%
ROIC	-11.92%
ROCE	-15.77%

Debt/Equity	N/A
Net debt/EBITDA	3.26
Current ratio	9.86
Quick ratio	9.41

Volatility	4.28%
Beta	0.45

RSI	36.12

Range	$2.32 – $2.38
52 weeks	$1.72 – $3.59
SMA 50	$3 -11.75%
SMA 200	$3 -28.79%

1 year target	$1 -36.64%
Mean Recomm.	3.00

Insider ownership	17.10%
Inst. ownership	0.38%

Shares outst.	10.140M
Shares float	0.000 0.00%
Short % of float	0.09%
Short ratio	0.34

1 year target	$1 -36.64%
Mean Recomm.	3.00

Dividend	N/A
Dividend yield	N/A
Payout ratio	N/A
Payment date	N/A
Ex-dividend date	N/A
Earnings date	N/A

IPO year	2011
Country	Canada

Compare with other stocks

AXDX

Accelerate Diagnostics Inc

Compare

Market cap	$45.21M
Enterprise value	N/A

Revenue	$12.233M
EBITDA	N/A
Income	-$37.91
Revenue Q/Q	2.23%
Revenue Y/Y	4.87%

P/E	0.00
Forward P/E	-4.38
EV/Sales	7.30
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	3.70
P/FCF	N/A
Price/Book	-2.27
Book/Share	-0.71
Cash/Share	0.47
FCF yield	-73.94%

Employees	184
RPE	$66.484k

Volume	20.573k / 59.867k
Relative vol.	0.34 ×

EPS	N/A
EPS Q/Q	-36.11%
Est. EPS Q/Q	26.67%

Profit margin	-510.97%
Oper. margin	-360.84%
Gross margin	21.15%
EBIT margin	-227.57%
EBITDA margin	-609.36%

Ret. on assets	-122.00%
Ret. on equity	131.18%
ROIC	-110.03%
ROCE	-294.47%

Debt/Equity	-2.58
Net debt/EBITDA	-2.79
Current ratio	1.28
Quick ratio	1.04

Volatility	7.93%
Beta	0.32

RSI	46.35

Range	$1.53 – $1.68
52 weeks	$0.73 – $7.00
SMA 50	$2 +5.86%
SMA 200	$1 +27.98%

1 year target	$15 +831.68%
Mean Recomm.	2.20

Insider ownership	33.24%
Inst. ownership	32.10%

Shares outst.	23.679M
Shares float	0.000 0.00%
Short % of float	6.79%
Short ratio	17.84

1 year target	$15 +831.68%
Mean Recomm.	2.20

Dividend	N/A
Dividend yield	N/A
Payout ratio	N/A
Payment date	N/A
Ex-dividend date	N/A
Earnings date	7 Nov 2024

IPO year	1996
Country	United States

Compare with other stocks

ARAY

Accuray Inc

Compare

Market cap	$180.02M
Enterprise value	$491.65M

Revenue	$430.554M
EBITDA	$10.013M
Income	-$21.49
Revenue Q/Q	-14.34%
Revenue Y/Y	-2.00%

P/E	N/A
Forward P/E	37.06
EV/Sales	1.14
EV/EBITDA	49.10
EV/EBIT	N/A
PEG	0.68
Price/Sales	0.42
P/FCF	N/A
Price/Book	3.35
Book/Share	0.59
Cash/Share	1.00
FCF yield	-13.37%

Employees	1,122
RPE	$383.738k

Volume	357.826k / N/A
Relative vol.	N/A

EPS	N/A
EPS Q/Q	300.00%
Est. EPS Q/Q	100.00%

Profit margin	-2.07%
Oper. margin	-1.57%
Gross margin	34.40%
EBIT margin	-4.10%
EBITDA margin	2.33%

Ret. on assets	-4.54%
Ret. on equity	-44.46%
ROIC	-1.43%
ROCE	-6.68%

Debt/Equity	7.93
Net debt/EBITDA	51.19
Current ratio	1.58
Quick ratio	0.78

Volatility	7.92%
Beta	2.25

RSI	48.35

Range	$1.92 – $2.02
52 weeks	$1.41 – $3.10
SMA 50	$2 +2.86%
SMA 200	$2 -3.99%

1 year target	$7 +255.33%
Mean Recomm.	1.00

Insider ownership	2.58%
Inst. ownership	68.38%

Shares outst.	99.244M
Shares float	0.000 0.00%
Short % of float	5.45%
Short ratio	11.08

1 year target	$7 +255.33%
Mean Recomm.	1.00

Dividend	N/A
Dividend yield	N/A
Payout ratio	N/A
Payment date	N/A
Ex-dividend date	N/A
Earnings date	5 Nov 2024

IPO year	2007
Country	United States

Compare with other stocks

ACRX

Acelrx Pharmaceuticals Inc

Compare

Market cap	$287.56M
Enterprise value	N/A

Revenue	$622.000k
EBITDA	N/A
Income	-$26.48
Revenue Q/Q	-76.92%
Revenue Y/Y	N/A

P/E	0.00
Forward P/E	-0.27
EV/Sales	8.22
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	462.31
P/FCF	N/A
Price/Book	13.18
Book/Share	0.08
Cash/Share	0.08
FCF yield	-6.64%

Employees	46
RPE	$13.522k

Volume	240.995k / 42.509k
Relative vol.	5.67 ×

EPS	N/A
EPS Q/Q	-12,100.00%
Est. EPS Q/Q	-14.29%

Profit margin	2,696.50%
Oper. margin	-3,221.70%
Gross margin	-46.30%
EBIT margin	-3,311.25%
EBITDA margin	-1,019.54%

Ret. on assets	-74.46%
Ret. on equity	-131.91%
ROIC	78.04%
ROCE	-104.62%

Debt/Equity	1.18
Net debt/EBITDA	1.67
Current ratio	4.04
Quick ratio	4.04

Volatility	11.23%
Beta	0.85

RSI	45.25

Range	$0.78 – $0.88
52 weeks	$0.42 – $1.61
SMA 50	$1 -29.07%
SMA 200	$1 -49.46%

1 year target	$5 +477.91%
Mean Recomm.	N/A

Insider ownership	1.20%
Inst. ownership	11.78%

Shares outst.	16.952M
Shares float	0.000 0.00%
Short % of float	6.85%
Short ratio	10.78

1 year target	$5 +477.91%
Mean Recomm.	N/A

Dividend	N/A
Dividend yield	N/A
Payout ratio	N/A
Payment date	N/A
Ex-dividend date	N/A
Earnings date	N/A

IPO year	2011
Country	United States

Compare with other stocks

ACOR

Acorda Therapeutics Inc

Compare

Market cap	$12.70M
Enterprise value	$569.58M

Revenue	$118.290M
EBITDA	-$4.08
Income	-$252.85
Revenue Q/Q	20.70%
Revenue Y/Y	-0.79%

P/E	N/A
Forward P/E	-18.33
EV/Sales	4.82
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	0.11
P/FCF	N/A
Price/Book	-0.08
Book/Share	-8.21
Cash/Share	1.59
FCF yield	-112.15%

Employees	344
RPE	$343.866k

Volume	321.668k / N/A
Relative vol.	N/A

EPS	N/A
EPS Q/Q	3.62%
Est. EPS Q/Q	-55.60%

Profit margin	-214.95%
Oper. margin	-233.43%
Gross margin	87.01%
EBIT margin	-224.84%
EBITDA margin	-3.45%

Ret. on assets	-83.28%
Ret. on equity	-2,206.93%
ROIC	-104.93%
ROCE	221.80%

Debt/Equity	-1.69
Net debt/EBITDA	80.97
Current ratio	0.33
Quick ratio	0.26

Volatility	159.68%
Beta	0.59

RSI	15.87

Range	$0.66 – $0.66
52 weeks	$0.61 – $18.00
SMA 50	$6 -835.06%
SMA 200	$11 -1,496.15%

1 year target	$2 +253.03%
Mean Recomm.	2.33

Insider ownership	0.69%
Inst. ownership	27.41%

Shares outst.	24.338M
Shares float	0.000 0.00%
Short % of float	2.28%
Short ratio	0.25

1 year target	$2 +253.03%
Mean Recomm.	2.33

Dividend	N/A
Dividend yield	N/A
Payout ratio	N/A
Payment date	N/A
Ex-dividend date	N/A
Earnings date	N/A

IPO year	2006
Country	United States

Compare with other stocks

ADOM

Envirotech Vehicles Inc

Compare

Market cap	$82.21M
Enterprise value	N/A

Revenue	N/A
EBITDA	N/A
Income	-$840.77
Revenue Q/Q	717.54%
Revenue Y/Y	N/A

P/E	N/A
Forward P/E	N/A
EV/Sales	68.36
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	66.22
P/FCF	N/A
Price/Book	-174.11
Book/Share	0.00
Cash/Share	N/A
FCF yield	-19.06%

Employees	5
RPE	N/A

Volume	557.386k / 462.649k
Relative vol.	1.20 ×

EPS	0.00
EPS Q/Q	-100.00%
Est. EPS Q/Q	0.00%

Profit margin	N/A
Oper. margin	-158.67%
Gross margin	N/A
EBIT margin	-175.19%
EBITDA margin	-199.55%

Ret. on assets	-32.89%
Ret. on equity	-110.80%
ROIC	-4.41%
ROCE	-3.46%

Debt/Equity	N/A
Net debt/EBITDA	N/A
Current ratio	22.88
Quick ratio	21.92

Volatility	12.97%
Beta	0.00

RSI	34.22

Range	$0.27 – $0.29
52 weeks	$0.28 – $0.28
SMA 50	$0 +25.00%
SMA 200	$0 +22.62%

1 year target	$0 +60.71%
Mean Recomm.	1.00

Insider ownership	20.65%
Inst. ownership	5.65%

Shares outst.	294.318M
Shares float	0.000 0.00%
Short % of float	1.33%
Short ratio	0.87

1 year target	$0 +60.71%
Mean Recomm.	1.00

Dividend	N/A
Dividend yield	N/A
Payout ratio	N/A
Payment date	N/A
Ex-dividend date	N/A
Earnings date	N/A

IPO year	2017
Country	United States

Compare with other stocks

ADXS

Ayala Pharmaceuticals Inc.

Compare

Market cap	$2.45M
Enterprise value	-$31.07

Revenue	$500.000k
EBITDA	-$15.27
Income	-$15.38
Revenue Q/Q	N/A
Revenue Y/Y	N/A

P/E	N/A
Forward P/E	-0.14
EV/Sales	N/A
EV/EBITDA	2.04
EV/EBIT	1.97
PEG	N/A
Price/Sales	9.81
P/FCF	N/A
Price/Book	0.00
Book/Share	5.20
Cash/Share	0.65
FCF yield	-622.02%

Employees	45
RPE	$11.111k

Volume	4.000 / N/A
Relative vol.	N/A

EPS	N/A
EPS Q/Q	N/A
Est. EPS Q/Q	-55.56%

Profit margin	-2,316.60%
Oper. margin	-7,724.00%
Gross margin	100.00%
EBIT margin	-5,723.60%
EBITDA margin	-3,053.60%

Ret. on assets	-41.01%
Ret. on equity	-45.76%
ROIC	-39.36%
ROCE	2,070.18%

Debt/Equity	1.07
Net debt/EBITDA	6.92
Current ratio	0.53
Quick ratio	0.53

Volatility	86.59%
Beta	0.00

RSI	32.00

Range	$0.02 – $0.02
52 weeks	$0.02 – $1.49
SMA 50	$0 -27.78%
SMA 200	$0 -1,957.98%

1 year target	$5 +24,900.00%
Mean Recomm.	N/A

Insider ownership	0.01%
Inst. ownership	0.10%

Shares outst.	49.300M
Shares float	0.000 0.00%
Short % of float	2.19%
Short ratio	0.95

1 year target	$5 +24,900.00%
Mean Recomm.	N/A

Dividend	N/A
Dividend yield	N/A
Payout ratio	N/A
Payment date	N/A
Ex-dividend date	N/A
Earnings date	N/A

IPO year	2005
Country	United States

Compare with other stocks

AEMD

Aethlon Medical Inc

Compare

Market cap	$4.08M
Enterprise value	N/A

Revenue	$0.00
EBITDA	N/A
Income	-$11.50
Revenue Q/Q	N/A
Revenue Y/Y	N/A

P/E	0.00
Forward P/E	-0.57
EV/Sales	N/A
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	N/A
P/FCF	N/A
Price/Book	0.71
Book/Share	0.53
Cash/Share	0.51
FCF yield	-230.75%

Employees	34
RPE	$0.00

Volume	726.960k / 962.800k
Relative vol.	0.76 ×

EPS	N/A
EPS Q/Q	38.46%
Est. EPS Q/Q	6.25%

Profit margin	N/A
Oper. margin	N/A
Gross margin	N/A
EBIT margin	N/A
EBITDA margin	-951.91%

Ret. on assets	-107.14%
Ret. on equity	-141.90%
ROIC	-94.80%
ROCE	-123.81%

Debt/Equity	0.43
Net debt/EBITDA	7.42
Current ratio	4.49
Quick ratio	4.49

Volatility	19.14%
Beta	0.81

RSI	45.48

Range	$0.36 – $0.41
52 weeks	$0.25 – $2.93
SMA 50	$0 -2.95%
SMA 200	$1 -150.08%

1 year target	$9 +2,287.27%
Mean Recomm.	1.00

Insider ownership	1.10%
Inst. ownership	4.34%

Shares outst.	13.937M
Shares float	0.000 0.00%
Short % of float	1.22%
Short ratio	1.45

1 year target	$9 +2,287.27%
Mean Recomm.	1.00

Dividend	N/A
Dividend yield	N/A
Payout ratio	N/A
Payment date	N/A
Ex-dividend date	N/A
Earnings date	14 Nov 2024

IPO year	2000
Country	United States

Compare with other stocks

AIMT

Aimmune Therapeutics Inc

Compare

Market cap	$2.26B
Enterprise value	N/A

Revenue	N/A
EBITDA	N/A
Income	-$287.03
Revenue Q/Q	N/A
Revenue Y/Y	N/A

P/E	0.00
Forward P/E	N/A
EV/Sales	3,769.86
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	3,832.47
P/FCF	N/A
Price/Book	17.87
Book/Share	1.59
Cash/Share	N/A
FCF yield	-10.38%

Employees	0
RPE	N/A

Volume	2.928M / 0.000
Relative vol.	N/A

EPS	N/A
EPS Q/Q	4.95%
Est. EPS Q/Q	-6.80%

Profit margin	N/A
Oper. margin	-49,193.39%
Gross margin	N/A
EBIT margin	-47,729.39%
EBITDA margin	-42,733.57%

Ret. on assets	-92.73%
Ret. on equity	-170.95%
ROIC	-89.30%
ROCE	-85.16%

Debt/Equity	N/A
Net debt/EBITDA	2.53
Current ratio	7.53
Quick ratio	7.40

Volatility	8.35%
Beta	0.00

RSI	28.78

Range	$5.22 – $5.45
52 weeks	$28.40 – $28.40
SMA 50	$34 -21.44%
SMA 200	$34 -21.44%

1 year target	$33 +17.46%
Mean Recomm.	N/A

Insider ownership	N/A
Inst. ownership	N/A

Shares outst.	65.450M
Shares float	0.000 0.00%
Short % of float	9.03%
Short ratio	0.99

1 year target	$33 +17.46%
Mean Recomm.	N/A

Dividend	N/A
Dividend yield	N/A
Payout ratio	N/A
Payment date	N/A
Ex-dividend date	N/A
Earnings date	N/A

IPO year	2015
Country	United States

Compare with other stocks